Metromedi Health Technologies Profile
Key Indicators
- Authorised Capital ₹ 11.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 10.83 Cr
as on 05-07-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.00 Cr
as on 05-07-2024
- Revenue 8.69%
(FY 2023)
- Profit 8.65%
(FY 2023)
- Ebitda 23.58%
(FY 2023)
- Net Worth 0.74%
(FY 2023)
- Total Assets 9.49%
(FY 2023)
About Metromedi Health Technologies
The Corporate was formerly known as Medrem Pharma Private Limited. The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 10.83 Cr.
The company currently has active open charges totaling ₹10.00 Cr.
Janaki Byra and Dileep Chakravarthy serve as directors at the Company.
- CIN/LLPIN
U52609TG2018PTC123145
- Company No.
123145
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Manikonda, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Metromedi Health Technologies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dileep Chakravarthy  | Managing Director | 28-Nov-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Janaki Byra | Director | 20-Mar-2018 | Current |
Financial Performance and Corporate Structure Insights of Metromedi Health Technologies.
Metromedi Health Technologies Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.69% increase. The company also saw a slight improvement in profitability, with a 8.65% increase in profit. The company's net worth moved up by a moderate rise of 0.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Metromedi Health Technologies?
In 2023, Metromedi Health Technologies had a promoter holding of 74.00% and a public holding of 26.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ven Soft India Private LimitedActive 26 years 8 monthsJanaki Byra and Dileep Chakravarthy are mutual person
Value Health Technologies Private LimitedActive 13 years 11 monthsJanaki Byra and Dileep Chakravarthy are mutual person
- Allure Business Park Private LimitedActive 2 years 8 months
Janaki Byra and Dileep Chakravarthy are mutual person
- Sri Dira Constructions And Developers Private LimitedActive 1 year 2 months
Janaki Byra is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Mar 2022 | ₹2.00 Cr | Open |
Others Creation Date: 18 Dec 2020 | ₹8.00 Cr | Open |
How Many Employees Work at Metromedi Health Technologies?
Unlock and access historical data on people associated with Metromedi Health Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Metromedi Health Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Metromedi Health Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
